Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine

Journal of Infectious Diseases

Volumn 166, Issue 6, 1992, Pages 1223-1227

  Gallant, Joel E ^a,b   Moore, Richard D ^a,b   Richman, Douglas D ^a,b   Keruly, Jeanne ^a,b   Chaisson, Richard E ^a,b   Bartlett, John ^a   McAvinue, Sharon ^a   Bryson, Yvonne ^c   Cohen, Helene ^c   Fischl, Margaret ^d   Bolin, Terry ^d   Kessler, Harold ^e   Burrough, Yvonne ^e   Mildvan, Donna ^f   Fox, Alice ^f   Freeman, Ben ^b   Simon, Gary ^g   Grabowy, Kathy Ward ^g   Chernoff, David ^h   Duff, Patricia ^h   Thompson, Sumner ⁱ   Barrett, Kara ⁱ   Awe, Robert ^j   Chapman, Ruby ^j   Leonard, Shirley ^j   Turner, Paul ^k   Hawkins, Marge ^k   Murray, Henry ^l   Bowers, Jill ^l   Lane, Clifford ^m   Tilson, Hugh ⁿ   Andrews, Elizabeth ⁿ   Smiley, Lynn ⁿ   more..

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MIAMI   (United States)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

^f BETH ISRAEL MEDICAL CENTER   (United States)

^g GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ EMORY UNIVERSITY   (United States)

^j Lyndon Baines Johnson Hospital   (United States)

^k KAISER PERMANENTE MEDICAL CENTER   (United States)

^l Kaiser Permanente Medical Group ^*  (United States)

^m NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

ⁿ Burroughs Wellcome Co   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL FEATURE; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL RATE; VIREMIA;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; COLITIS; CYTOMEGALOVIRUS INFECTIONS; ESOPHAGITIS; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HOMOSEXUALITY; HUMAN; INCIDENCE; MALE; PROBABILITY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RETINITIS; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; ZIDOVUDINE;

EID: 0026479981     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/166.6.1223     Document Type: Article

References (27)

1. Jacobson MA, Mills J. Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1988; 108: 585-94.
2. Drew WL, Mintz L, Miner RC, Sands M, Ketterer B. Prevalence of cytomegalovirus infection in homosexual men. J Infect Dis 1981;143:188-92.
3. Quinnan GV, Masur H, Rook AH, et al. Herpesvirus infections in the acquired immune deficiency syndrome. JAMA 1984;252:72-7.
4. Lange M, Klein EB, Kornfield H, Cooper LZ, Grieco MH, Cytomegalovirus isolation from healthy homosexual men. JAMA 1984;252: 1908-10.
5. Collier AC, Meyers JD, Corey L, Murphy VL, Roberts PL, Handsfield HH. Cytomegalovirus infection in homosexual men: relationship to sexual practices, antibody to human immunodeficiency virus, and cell-mediated immunity. Am J Med 1987;82:593-601.
6. Quinn TC, Piot P, McCormick JB, et al. Serologic and immunologic studies in patients with AIDS in North America and Africa: the potential role of infectious agents as cofactors in human immunodeficiency virus infection. JAMA 1987;257:2617-21.
7. Sullivan JL, Brewster FE, Brettler DB, et al. Hemophiliac immunodeficiency: influence of exposure to factor VIII concentrate, LAV/HTLV-III, and herpesviruses. J Pediatr 1986;108:504-10.
8. Jordan MC. Latent infection and the elusive cytomegalovirus. Rev Infect Dis 1983;5:205-15.
9. Armstrong D, Gold JWM, Dryjanski J, et al. Treatment of infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1985;103:738-43.
10. Reichert CM, O’Leary TJ, Levens DL, Simrell CR, Macher AM. Autopsy pathology in the acquired immune deficiency syndrome. Am J Pathol 1983;112:357-82.
11. Drew WL. Cytomegalovirus infection in patients with AIDS. Clin Infect Dis 1992;14:608-15.
12. Wilkes MS, Fortin AH, Felix JC, Godwin TA, Thompson WG. Value of necropsy in acquired immunodeficiency syndrome. Lancet 1988;2:85-8.
13. Fischl MA, Richman DD, Grieco MH, et al. The efficacy of azidothy- midine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial. N Engl J Med 1987;317:185-91.
14. Creagh-Kirk T, Doi P, Andrews E, et al. Survival experience among patients with AIDS receiving zidovudine: follow-up of patients in a compassionate plea program. JAMA 1988;260:3009-15.
15. Moore RD, Hidalgo J, Sugland BW, Chaisson RE. Zidovudine and the natural history of the acquired immunodeficiency syndrome. N Engl J Med 1991;324:1412-6.
16. Fischl MA, Dickinson GM, La Voie L. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. JAMA 1988;259:1185-9.
17. Leoung GS, Feigal DW Jr, Montgomery AB, et al. Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco Community Consortium Trial. N Engl J Med 1990;323:769-75.
18. Chaisson RE, Keruly JC, Richman DD, Moore RD, Zidovudine Epidemiology Study Group. Pneumocystis prophylaxis and survival in patients with advanced HIV infection treated with zidovudine. Arch Intern Med (in press).
19. Graham NM, Zeger SL, Park LP, et al. The effects on survival of early treatment of human immunodeficiency virus infection. N Engl J Med 1992;326:1037-42.
20. Moore RD, Creagh-Kirk T, Keruly J, et al. Long-term safety and efficacy of zidovudine in patients with advanced human immunodeficiency virus disease. Arch Intern Med 1991;151:981-6.
21. Moore RD, Kessler H, Richman DD, Flexner C, Chaisson RE. Non- Hodgkin’s lymphoma in patients with advanced HIV infection treated with zidovudine. JAMA 1991;265:2208-11.
22. Chaisson RE, Moore RD, Richman DD, Keruly J, Creagh-Kirk T, Zidovudine Epidemiology Study Group. Incidence and natural history of Mycobacterium avium complex infections in patients with advanced HIV disease treated with zidovudine. Am Rev Respir Dis 1992;146:285-9.
23. Tsai WY, Jewell NP, Wang MC. A note on the product-limit estimator under right censoring and left truncation. Biometrika 1987;74:883-6.
24. Millar AB, Patou G, Miller RF, et al. Cytomegalovirus in the lungs of patients with AIDS. Respiratory pathogen or passenger? Am Rev Respir Dis 1990;141:1474-7.
25. Jacobson MA, Mills J, Rush J, et al. Morbidity and mortality of patients with AIDS and first-episode Pneumocystis carinii pneumonia unaffected by concomitant pulmonary cytomegalovirus infection. Am Rev Respir Dis 1991;144:6-9.
26. Bozzette SA, Arcia J, Bartók AE, et al. Impact of Pneumocystis carinii and cytomegalovirus on the course and outcome of atypical pneumonia in advanced human immunodeficiency virus disease. J Infect Dis 1992;165:93-8.
27. Studies of Ocular Complications of AIDS Research Group. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med 1992;326:213-20.